InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the full record of transactions filed by Lydon Nicholas, Director. Insider active across 1 company, notably Blueprint Medicines Corp. Cumulatively, 6 reports have been logged. Activity tracked since 2 June 2021. The latest transaction was filed on 12 June 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations6 total
2,242 shares0Common StockSEC:0001415889-24-016982:0
2,600 shares0Common StockSEC:0001415889-23-010257:0
2,600 shares0Common StockSEC:0001415889-22-007132:0
10,909 shares@ US$19.53100.0% of flowCommon StockSEC:0001415889-22-005656:0
2,250 shares0Common StockSEC:0001179110-21-006414:0
2,250 shares0Common StockSEC:0001179110-21-006414
6 of 6 declarations
About Lydon Nicholas
Nicholas Lydon is a Board Member at Blueprint Medicines Corp. He plays a key role in the governance of the company, contributing to strategic decision-making and overseeing activities.
